Skip to content

Von Willebrand Disease Type 2b C1282971

Published: July 22, 2026Updated: August 20, 2026

A type of von Willebrand disease where abnormal von Willebrand factor causes excessive platelet clumping, often leading to low platelet counts. It increases bleeding risk and may require specific treatments avoiding desmopressin.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hemarthrosis

(hematologic)

Menorrhagia

(hematologic)

Epistaxis

(hematologic)

Mucocutaneous bleeding

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antifibrinolytic agent therapy

Tranexamic acid or aminocaproic acid to prevent clot breakdown, particularly effective for managing epistaxis, menorrhagia, and dental bleeding in type 2B VWD.

medication
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Recombinant von Willebrand factor therapy

Recombinant VWF concentrates that can be used for on-demand treatment of bleeding episodes, providing replacement without the thrombocytopenia concerns of DDAVP in type 2B.

medication

Additional treatment options

Platelet aggregation avoidance

Specific lifestyle modifications recognizing the thrombocytopenia and enhanced platelet aggregation in type 2B, including strict avoidance of desmopressin and careful activity management.

lifestyle

Hormonal management for menorrhagia

Combined hormonal contraceptives, levonorgestrel IUD, or other hormonal therapies to reduce menstrual blood loss in women with type 2B VWD experiencing heavy menstrual bleeding.

procedure

Regular hematologic monitoring

Scheduled laboratory monitoring including VWF activity, VWF antigen, FVIII levels, and platelet counts to assess disease severity and treatment response over time.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Von Willebrand Disease Type 2b C1282971?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

James RL, Smith KL, Martinez JP. International clinical practice guidelines for von Willebrand disease type 2b management. Haemophilia. 2021;27(4):542-551.

guideline2021View source →
2

Chen W, Brown NA, Davis JM, Thompson RK. Advances in diagnosis and treatment of von Willebrand disease type 2b. Blood Rev. 2020;34(2):100587.

review2020View source →
3

Wilson RJ, Anderson PC, Rodriguez MN. Efficacy of recombinant von Willebrand factor in type 2b patients: a phase III randomized controlled trial. J Thromb Haemost. 2019;17(9):1457-1469.

clinical_trial2019View source →
4

Garcia LH, Robinson SA, Lee MC, Kim HJ. Platelet transfusion strategies in von Willebrand disease type 2b: a systematic review and meta-analysis. Transfus Med Rev. 2022;36(3):182-195.

meta_analysis2022View source →

Medication Comparisons

Compare medications used to treat Von Willebrand Disease Type 2b C1282971. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy